文献速递预防保健、筛查与疫苗慢病管理

无症状男性前列腺癌风险预测算法的开发与验证

Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm.
PubMed 文献 · Br J Gen Pract · 2021-04-29

基于英国1098家全科诊所的队列数据,开发并验证了一个预测无症状男性10年前列腺癌绝对风险的方程。该方程纳入PSA水平、年龄、贫困程度、 ethnicity、吸烟状况、严重精神疾病、糖尿病、BMI和前列腺癌家族史,在验证队列中表现出良好的区分度和校准度。两步法在识别前列腺癌病例、高级别癌症和死亡方面均优于固定PSA阈值。

要点

  • 该风险方程纳入PSA、年龄、贫困、 ethnicity、吸烟、严重精神疾病、糖尿病、BMI和家族史。
  • 验证队列中Harrell's C-index为0.917(95%CI 0.915-0.919),R²为70.4%。
  • 两步法识别前列腺癌病例的敏感性为68.2%,高于固定PSA阈值的43.9%。

核心结论

  • 该风险方程能有效预测无症状男性10年前列腺癌绝对风险,对病例、高级别癌症和死亡的识别敏感性均高于基于年龄和PSA阈值的简单方法。

研究设计与样本

  • 队列研究,使用英国QResearch数据库中1098家全科诊所的常规数据开发模型,并采用两个独立诊所数据集进行验证。

主要发现

  • 风险方程纳入PSA水平、年龄、贫困程度、 ethnicity、吸烟状况、严重精神疾病、糖尿病、BMI和前列腺癌家族史。
  • 模型解释70.4%(95%CI 69.2-71.6)的诊断时间变异(R²),D统计量为3.15(95%CI 3.06-3.25),Harrell's C-index为0.917(95%CI 0.915-0.919)。
  • 两步法识别前列腺癌病例的敏感性为68.2%,固定PSA阈值为43.9%;识别高级别癌症的敏感性为49.2% vs 40.3%;识别死亡的敏感性为67.0% vs 31.5%。

关键数值与推荐

  • 风险方程包含PSA水平、年龄、贫困程度、 ethnicity、吸烟状况、严重精神疾病、糖尿病、BMI和前列腺癌家族史。
  • 两步法在识别前列腺癌病例、高级别癌症和死亡方面的敏感性均高于固定PSA阈值。

临床怎么用

  • 在全科实践中,可基于PSA、年龄、贫困、 ethnicity、吸烟、严重精神疾病、糖尿病、BMI和家族史计算10年前列腺癌绝对风险。
  • 采用两步法(先风险评估再决策)可能比单纯固定PSA阈值更有效地识别前列腺癌病例、高级别癌症和死亡高风险男性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diagnosis of prostate cancer at an early stage can potentially identify tumours when intervention may improve treatment options and survival. AIM: To develop and validate an equation to predict absolute risk of prostate cancer in asymptomatic men with prostate specific antigen (PSA) tests in primary care. DESIGN AND SETTING: Cohort study using data from English general practices, held in the QResearch database. METHOD: Routine data were collected from 1098 QResearch English general practices linked to mortality, hospital, and cancer records for model development. Two separate sets of practices were used for validation. In total, there were 844 455 men aged 25-84 years with PSA tests recorded who were free of prostate cancer at baseline in the derivation cohort; the validation cohorts comprised 292 084 and 316 583 men. The primary outcome was incident prostate cancer. Cox proportional hazards models were used to derive 10-year risk equations. Measures of performance were determined in both validation cohorts. RESULTS: There were 40 821 incident cases of prostate cancer in the derivation cohort. The risk equation included PSA level, age, deprivation, ethnicity, smoking status, serious mental illness, diabetes, BMI, and family history of prostate cancer. The risk equation explained 70.4% (95% CI = 69.2 to 71.6) of the variation in time to diagnosis of prostate cancer (R2) (D statistic 3.15, 95% CI = 3.06 to 3.25; Harrell's C-index 0.917, 95% CI = 0.915 to 0.919). Two-step approach had higher sensitivity than a fixed PSA threshold at identifying prostate cancer cases (identifying 68.2% versus 43.9% of cases), high-grade cancers (49.2% versus 40.3%), and deaths (67.0% versus 31.5%). CONCLUSION: The risk equation provided valid measures of absolute risk and had higher sensitivity for incident prostate cancer, high-grade cancers, and prostate cancer mortality than a simple approach based on age and PSA threshold.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Hippisley-Cox J, Coupland C. Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm. Br J Gen Pract. 2021. PMID: 33875417. doi:10.3399/bjgp20X714137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。